Deftbiotech Overview

  • Status
  • Private

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $706K

  • Investors
  • 2

Deftbiotech General Information

Description

Developer of antifungal therapeutic agents designed for the treatment of human skin and nail infections. The company is advancing a novel peptide-based compound from the plant defensin family that rapidly eliminates multiple fungal pathogens through a different mechanism from existing treatments, enabling healthcare providers and patients to access effective treatment for onychomycosis and related conditions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Melbourne, Victoria
  • Australia
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Life Sciences
Corporate Office
  • Melbourne, Victoria
  • Australia

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Deftbiotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 19-Mar-2026 $706K Completed Pre-Clinical Trials
To view Deftbiotech’s complete valuation and funding history, request access »

Deftbiotech Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Pre-seed Preference
To view Deftbiotech’s complete cap table history, request access »

Deftbiotech Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Breakthrough Victoria Venture Capital Minority
La Trobe University University Minority
To view Deftbiotech’s complete investors history, request access »

Ready to get started?

Request a free trial

Deftbiotech FAQs

  • Where is Deftbiotech headquartered?

    Deftbiotech is headquartered in Melbourne, Australia.

  • What industry is Deftbiotech in?

    Deftbiotech’s primary industry is Biotechnology.

  • Is Deftbiotech a private or public company?

    Deftbiotech is a Private company.

  • What is the current valuation of Deftbiotech?

    The current valuation of Deftbiotech is .

  • What is Deftbiotech’s current revenue?

    The current revenue for Deftbiotech is .

  • How much funding has Deftbiotech raised over time?

    Deftbiotech has raised $706K.

  • Who are Deftbiotech’s investors?

    Breakthrough Victoria and La Trobe University have invested in Deftbiotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process